EV/EBITDA
-4.19
+0.16+3.68%
Wed, 26 Feb 2025 21:00:11 GMT
Summary
- As of February 27, 2025, CTNM EV/EBITDA is -4.19, with a rise of +0.16 (+3.68%) during the most recent trading day.
- CTNM EV/EBITDA is now -115.15% below its all-time high of 27.66.
Performance
CTNM EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CTNM EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +3.7% | -3.5% | -2.8% |
1 m1 month | +40.1% | -40.1% | -34.5% |
3 m3 months | +57.8% | -57.8% | -51.8% |
6 m6 months | +69.6% | -65.8% | -63.1% |
ytdytd | +56.0% | -56.0% | -50.0% |
1 y1 year | - | - | - |
5 y5 years | - | - | - |
CTNM EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -2.4% | -7.00 | +40.1% | |
3 m | 3-month | -4.09 | -2.4% | -9.93 | +57.8% |
6 m | 6-month | -4.09 | -2.4% | -13.79 | +69.6% |
1 y | 1-year | 27.66 | -115.2% | -15.32 | +72.7% |
3 y | 3-year | 27.66 | -115.2% | -15.32 | +72.7% |
5 y | 5-year | 27.66 | -115.2% | -15.32 | +72.7% |
alltime | all time | 27.66 | -115.2% | -15.32 | +72.7% |
Contineum Therapeutics Class A EV/EBITDA History
Date | Value |
---|---|
2025 | -4.19(-56.0%) |
Date | Value |
---|---|
2024 | -9.53 |
FAQ
- What is Contineum Therapeutics Class A EV/EBITDA?
- What is the all time high EV/EBITDA for Contineum Therapeutics Class A?
- What is CTNM EV/EBITDA year-to-date change?
What is Contineum Therapeutics Class A EV/EBITDA?
The current EV/EBITDA of CTNM is -4.19
What is the all time high EV/EBITDA for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high EV/EBITDA is 27.66
What is CTNM EV/EBITDA year-to-date change?
Contineum Therapeutics Class A EV/EBITDA has changed by +5.34 (+56.03%) since the beginning of the year